Organon Denmark ApS
CVR: 41193093
Organon Denmark ApS demonstrates a stable financial trajectory with consistent revenue growth, increasing from 49.2 million DKK in 2020 to 74.1 million DKK in 2024. Profitability has fluctuated, peaking at 2.9 million DKK in 2023 before declining to 2.4 million DKK in 2024, indicating potential concerns regarding profit margins. The company's equity position remains strong at 27.9 million DKK, although it has seen a slight decline from the previous year. Positioned within the wholesale trade of pharmaceuticals and healthcare products, Organon Denmark ApS appears to be a solid player in its industry, though attention to profit sustainability may be warranted.
AI-generated summary
Overview
- Company type
- APS
- Anpartsselskab
- Founded
- 24.2.2020
Details
- Capital
- 40.010 kr.
Contact
Advertising protectedPurpose
Selskabets formål er at udøve virksomhed indenfor industri og handel samt al virksomhed, som efter direktionens skøn har forbindelse hermed.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 74.1 mio. | 2.4 mio. | 41.6 mio. | 27.9 mio. | 15 | |
History
Ownership
Management
Directors
Founders
Production units (1)
Similar companies
Companies in the same industry and area